Company Reports Q4 Revenue of $61.2M, Up from $56.9M Last Year
Reports Q4 revenue $61.2M vs. $56.9M last year. Revenue growth was driven by increased patient visits, clinical hours, and fee and reimbursement growth, highlighted by same practice revenue growth of 6.3%. "We are pleased to report a strong finish to a very successful year. We achieved record revenue and adjusted EBITDA in 2025 and successfully completed our initial public offering in December," said CEO Pete Swenson.
